Within seven days following peroral high dose infection with Toxoplasma gondii susceptible conventionally colonized mice develop acute ileitis due to an underlying T helper cell (Th) -1 type immunopathology. We here addressed whether mice harboring a human intestinal microbiota developed intestinal, extra-intestinal and systemic sequelae upon ileitis induction.
Secondary abiotic mice were generated by broad-spectrum antibiotic treatment and associated with a complex human intestinal microbiota following peroral fecal microbiota transplantation. Within three weeks the human microbiota had stably established in the murine intestinal tract as assessed by quantitative cultural and culture-independent (i.e. molecular 16S rRNA based) methods. At day 7 post infection (p.i.) with 50 cysts of T. gondii strain ME49 by gavage human microbiota associated (hma) mice displayed severe clinical, macroscopic and microscopic sequelae indicating acute ileitis. In diseased hma mice increased numbers of innate and adaptive immune cells within the ileal mucosa and lamina propria and elevated intestinal secretion of pro-inflammatory mediators including IFN-γ, IL-12 and nitric oxide could be observed at day 7 p.i. Ileitis development was accompanied by substantial shifts in intestinal microbiota composition of hma mice characterized by elevated total bacterial loads and increased numbers of intestinal Gram-negative commensals such as enterobacteria and Bacteroides / Prevotella species overgrowing the small and large intestinal lumen. Furthermore, viable bacteria translocated from the inflamed ileum to extra-intestinal including systemic compartments. Notably, pro-inflammatory immune responses were not restricted to the intestinal tract as indicated by increased pro-inflammatory cytokine secretion in extra-intestinal (i.e. liver and kidney) and systemic compartments including spleen and serum.
With respect to the intestinal microbiota composition “humanized” mice display acute ileitis following peroral high dose T. gondii infection. Thus, hma mice constitute a suitable model to further dissect the interactions between pathogens, human microbiota and vertebrate host immunity during acute intestinal inflammation.
Citation: von Klitzing E, Ekmekciu I, Kühl AA, Bereswill S, Heimesaat MM (2017) Intestinal, extra-intestinal and systemic sequelae of Toxoplasma gondii induced acute ileitis in mice harboring a human gut microbiota. PLoS ONE12(4): e0176144. https://doi.org/10.1371/journal.pone.0176144
Editor: Michael E. Grigg, NIH, UNITED STATES
Received: January 11, 2017; Accepted: April 5, 2017; Published: April 17, 2017
Copyright: © 2017 von Klitzing et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by grants from the German Research Foundation (DFG) to EVK and IE (SFB633, Immuco), SB (SFB633, TP A7), MMH (SFB633, TP B6), and AAK (SFB633, TP Z1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Competing interests: SB and MMH serve as academic editors of this journal. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Within one week following peroral infection with a high dose (i.e. 50 to 100 cysts) of the intracellular parasite Toxoplasma gondii strain ME49 susceptible mice develop severe ileitis and succumb to infection [1–3]. Disease develops due to a classical T helper cell (Th1)-type hyper-inflammatory immune response that is characterized by a CD4+ T lymphocyte driven excessive secretion of pro-inflammatory mediators such as TNF, IFN-γ, nitric oxide (NO) and IL-12, whereas counter-regulatory measures include IL-10 production [3–7]. Ileitis development has been shown to be highly microbiota dependent , given that secondary abiotic mice with a virtually depleted intestinal microbiota were unaffected following T. gondii infection, whereas upon reconstitution with the murine intestinal microbiota mice were suffering from overt disease . Acute ileitis was further accompanied by a marked shift in the intestinal microbiota composition towards an overgrowth of the inflamed ileal lumen with commensals such as enterobacteria and Bacteroides / Prevotella spp. [3, 9, 10]. Toll-like receptor (TLR) -4 dependent signaling of lipopolysaccharide (LPS) derived from the overgrowing Gram-negative bacterial species such as E. coli further perpetuate the fatal immunopathological process . Overall, the high dose T. gondii infection model resembles key features of inflammatory bowel diseases (IBD) in humans such as Crohn’s disease during the acute stage [3, 9, 12].
Given the importance of the host specific intestinal microbiota in susceptibility towards distinct immunopathological diseases, their onset, progression and outcome [8, 13, 14], we generated with respect to their microbiota “humanized” mice in order to mimic human microbiota conditions for the investigations of the molecular mechanisms underlying pathogen-commensal bacterial-host interactions. To address this, conventional mice were subjected to broad-spectrum antibiotic treatment in order to virtually deplete the commensal intestinal microbiota [8, 9]. Secondary abiotic mice were then reassociated with a complex human intestinal microbiota by fecal microbiota transplantation (FMT) that could stably establish within the murine host for at least six weeks . In the present study we applied the human microbiota associated (hma) mouse model to unravel the triangle relationship between pathogen, human intestinal microbiota ecology and host immunity in acute T. gondii induced ileitis.
Material and methods
All animal experiments were conducted according to the European Guidelines for animal welfare (2010/63/EU) with approval of the commission for animal experiments headed by the “Landesamt für Gesundheit und Soziales” (LaGeSo, Berlin; registration number G0184/12). Animal welfare was monitored twice daily by assessment of clinical conditions and weight loss of mice. Mice suffering from weight loss >20% were euthanized by isoflurane treatment (Abott, Germany) in accordance with the guidelines of the local authorities (“human end points”).
Generation of human microbiota associated mice
Female C57BL/6j mice were bred under specific pathogen-free conditions in the Forschungseinrichtungen für Experimentelle Medizin (Charité—University Medicine, Berlin, Germany). Secondary abiotic mice with a virtually depleted microbiota were generated as described previously . In brief, eight weeks old mice were transferred into sterile cages and subjected to a broad-spectrum antibiotic treatment for eight weeks by adding ampicillin plus sulbactam (1 g/L; Ratiopharm, Germany), vancomycin (500 mg/L; Cell Pharm, Germany), ciprofloxacin (200 mg/L; Bayer Vital, Germany), imipenem (250 mg/L; MSD, Germany) and metronidazole (1 g/L; Fresenius, Germany) to the drinking water (ad libitum).
Three days prior reassociation of secondary abiotic mice with a complex human intestinal microbiota, antibiotic cocktail was replaced by autoclaved tap water (ad libitum). Fresh fecal samples free of enteropathogenic bacteria, viruses and parasites were collected from five individual healthy volunteers, dissolved in sterile phosphate buffered saline (PBS; Gibco, life technologies, UK)), aliquoted and stored at -80°C as described earlier . Immediately before reconstitution experiments, individual fecal aliquots were thawed, pooled, and the main bacterial communities within the donor suspension quantitatively assessed by culture and molecular methods as stated previously . To generate human intestinal microbiota associated (hma) mice, secondary abiotic animals were subjected to peroral fecal transplantations with 0.3 mL of the donor suspension by gavage on three consecutive days. Bacterial groups varied less than 0.5 logarithmic orders of magnitude between independent experiments. To assure proper establishment of the human microbiota in the murine host, mice were kept for three weeks until ileitis induction. Immediately before peroral T. gondii infection individual fecal samples were collected for quantitative cultural and molecular analyses of main intestinal bacterial communities as described elsewhere [9, 11, 14, 15].
Toxoplasma gondii infection and clinical conditions
In order to induce acute ileitis, hma were perorally subjected to high-dose T. gondii ME49 strain infection (i.e. with 50 cysts) by gavage as described previously [9, 11, 16, 17]. Body weights as well as macroscopic and / or microscopic abundances of fecal blood were assessed in individual mice on a daily basis by the Guajac method using Haemoccult (Beckman Coulter/ PCD, Germany). Noninfected hma mice served as negative controls.
Mice were sacrificed seven days after ileitis induction by isoflurane treatment (Abott, Germany). Cardiac blood, tissue samples from spleen, liver, lung, kidney, mesenteric lymph nodes (MLN), ileum and colon were removed under sterile conditions. Colonic and ileal samples from each mouse were collected in parallel for microbiological, immunological, immunohistochemical and histopathological analyses.
Small intestinal lengths and histopathological scores
Small intestinal lengths were determined by measuring the distance from the duodenum leaving the stomach to the ileal-caecal transition. Ex vivo biopsies derived from the terminal ileum were immediately fixed in 5% formalin and embedded in paraffin. Sections (5 μm) were stained with hematoxylin and eosin (H&E) and subjected to a standardized histopathological scoring system ranging from 0 to 6 as described earlier [9, 11].
Five μm thin paraffin sections of ileal ex vivo biopsies were used for in situ immunohistochemical analyses as described previously [15, 18, 19]. Primary antibodies against cleaved caspase-3 (Asp175, Cell Signaling, Boston, MA, USA, 1:200), CD3 (Polyclonal rabbit anti human, DAKO, Denmark; 1:10), FOXP3 (FJK-165, eBioscience, Germany; 1:100), B220 (eBioscience; 1:200) and F4/80 (biot. Clone BM 8 rat anti-mouse, Life Technologies, USA; 1:100) were used to assess apoptotic cells, T lymphocytes, regulatory T cells (Treg), B lymphocytes and macrophages / monocytes, respectively. The average number of positively stained cells within at least six high power fields (HPF, 0.287 mm2; 400 x magnification) were determined by an independent and blinded investigator.
Cultural survey of the human donor suspension, intestinal microbiota and bacterial translocation
For comprehensive quantitative survey of the microbiota composition in fecal human donor suspensions and intestinal (i.e. ileal and colonic) luminal contents as well as of viable bacteria translocating from the intestines to extra-intestinal compartments including MLN, liver, lung and spleen, respective intestinal samples and ex vivo biopsies were homogenized in sterile phosphate buffered saline (PBS, Gibco life technologies, UK) and analyzed in serial dilutions on respective solid media as described earlier [9, 11, 20]. Cardiac blood was directly streaked onto solid media. Bacteria were grown at 37°C for at least two days under aerobic, microaerobic and anaerobic conditions.
Molecular analysis of the human donor suspension and the ileal microbiota
DNA was extracted from the human donor suspension and intestinal luminal content as described previously . In brief, DNA was quantified by using Quant-iT PicoGreen reagent (Invitrogen, UK) and adjusted to 1 ng per μL. Then, main bacterial groups abundant in the murine and human intestinal microbiota were assessed by quantitative real-time polymerase chain reaction (qRT-PCR) with species-, genera- or group-specific 16S rRNA gene primers (Tib MolBiol, Germany) and numbers of 16S rRNA gene copies per ng DNA of each sample determined as described previously [14, 15, 21, 22].
Ex vivo biopsies of approximately 1cm2 (ileum and colon cut longitudinally) were washed in PBS and placed in 24-flat-bottom well culture plates (Falcon, Germany) containing 500 mL serum-free RPMI 1640 medium (Gibco, life technologies) supplemented with penicillin (100 U/mL, Biochrom, Germany) and streptomycin (100 μg/mL; Biochrom). After 18 hours at 37°C, culture supernatants and serum samples were tested for IFN-γ, TNF, MCP, IL-12p70, IL-6 and IL-10 by the Mouse Inflammation Cytometric Bead Assay (CBA; BD Bioscience) on a BD FACSCanto II flow cytometer (BD Bioscience). Nitric oxide (NO) was measured by the Griess reaction as described earlier .
Mean values, medians, standard deviations (SD) and levels of significance were determined using appropriate tests as indicated (two-tailed Student´s t-test, Mann-Whitney U test). Two-sided probability (p) values ≤0.05 were considered significant. Experiments were repeated at least twice.
Generation of human microbiota associated mice by fecal microbiota transplantation
In the present study we investigated intestinal, extra-intestinal and systemic sequelae of acute T. gondii induced ileitis in (with respect to the intestinal microbiota composition) “humanized” mice. To assure stable intestinal colonization of mice with a complex human microbiota, we initially generated secondary abiotic animals by quintuple antibiotic treatment for eight weeks. Subsequently, mice with a virtually depleted intestinal microbiota were subjected to peroral transplantation of human microbiota generated from five healthy human individuals on three consecutive days. Quantitative cultural as well as culture-independent (i.e. 16S rRNA based molecular) analyses revealed comparable microbiota compositions of respective human fecal suspensions (S1 Fig). Within three weeks the human microbiota had stably established within the murine intestinal tract (Fig 1).
Human microbiota associated (hma) were perorally infected with T. gondii strain ME49 to induce acute ileitis as described in methods. Main intestinal bacterial groups abundant in the ileum (A, B) and the colon lumen (C, D) of hma mice were quantitatively assessed applying both culture (A, C) and culture-independent (i.e. molecular 16S rRNA based; B, D) methods 7 days following ileitis induction (ILE, filled circles). Noninfected hma mice served as controls (N, open circles). Numbers of enterobacteria (EB), enterococci (EC), Gram-positive rods (GPR), Bacteroides / Prevotella spp. (B/P), Clostridium / Eubacterium spp. (C/E) and the total bacterial loads (TL) are expressed as colony forming units per gram feces (CFU / g). 16S rRNA of the main intestinal bacterial groups including enterobacteria (EB), enterococci (EC), lactobacilli (LB), bifidobacteria (Bif), Bacteroides / Prevotella species (B/P), Clostridium coccoides group (Clocc), Clostridium leptum group (Clept), Mouse Intestinal Bacteroides (MIB) and the total eubacterial loads (TL) are expressed as gene numbers per ng DNA. Numbers of animals harboring the respective bacterial group out of the total number of analyzed mice are given in parentheses. Medians (black bars) and significance levels (p-values) determined by Student’s t test and Mann-Whitney U test are indicated. Data shown are pooled from three independent experiments.
Microbiota shifts during acute ileitis of human microbiota associated mice
In order to induce ileitis, hma mice were perorally infected with a high dose (i.e. 50 cysts) of T. gondii strain ME49 on day 0. As assessed by culture, the ileal loads of the main intestinal commensals including aerobic enterobacteria and enterococci as well as the obligate anaerobic Bacteroides / Prevotella spp. and Clostridium / Eubacterium spp. increased in hma mice within seven days post ileitis induction (p<0.05–0.001; Fig 1A). Molecular analyses additionally assessing fastidious or even uncultivable commensals confirmed cultural results and further revealed increased gene numbers of Mouse Intestinal Bacteroides (p<0.001), Clostridium leptum (p<0.05), but not C. coccoides (n.s.), whereas decreased 16S rRNA copies of lactobacilli (p<0.05) could be determined at day 7 p.i. as compared to uninfected hma control mice (Fig 1B). Notably, luminal microbiota shifts were not restricted to the inflamed distal small intestines as indicated by distinctly elevated enterobacteria, enterococci and Bacteroides / Prevotella spp. in the colonic lumen of T. gondii infected hma mice (p<0.01–0.001; Fig 1C and 1D). Conversely, numbers of cultivable Gram-positive rods (such as Bacillus spp. and lactobacilli; p<0.05; Fig 1C) as well as lactobacilli 16S rRNA gene copies decreased in the colon of hma mice during ileitis development (p<0.001; Fig 1D). Hence, acute ileitis is accompanied by pronounced shifts in the intestinal microbiota composition of hma mice.
Clinical, macroscopic and microscopic sequelae in T. gondii infected human microbiota associated mice
Until day 7 following T. gondii infection hma were clinically severely compromised and exhibited wasting and bloody diarrhea in almost 90% of cases (Fig 2A). Since intestinal inflammation is known to be associated with significant shortening of the inflamed gut in conventional mice [9, 14, 23, 24], we measured small intestinal lengths of hma mice at necropsy. In fact, T. gondii infected hma mice displayed shorter small intestines as compared to noninfected hma control animals (p<0.001, Fig 2B). Macroscopic sequelae of T. gondii infection were supported by microscopic intestinal inflammatory changes. Seven days post ileitis induction, all hma mice displayed high histopathological scores indicating severe ileal inflammation with destruction of the villous architecture, cellular shedding into the lumen and massive necrosis (p<0.001 vs noninfected controls; Fig 2C, S2A Fig). Furthermore, ileal apoptotic cell numbers increased multifold upon ileitis induction (p<0.001; Fig 2D, S2B Fig). Hence, T. gondii infection of hma mice results in severe macroscopic as well as microscopic inflammatory sequelae.
Human microbiota associated (hma) mice were perorally infected with T. gondii strain ME49 to induce acute ileitis (ILE; filled symbols). Noninfected hma mice served as controls (N, open symbols). Clinical, macroscopic and microscopic intestinal changes were assessed at day 7 following ileitis induction: (A) Abundance of blood was determined in fecal samples by the Guajac (Haemoccult) method. Means, standard deviations and numbers of fecal blood positive mice out of the total numbers of analyzed animals are given in parentheses. (B) Absolute small intestinal lengths were measured (in cm) and (C) histopathological changes were determined in H&E stained ileal paraffin sections applying a standardized scoring system (see methods). Scores ≥4 (dotted line) indicate severe inflammation with necrosis. (D) The average numbers of apoptotic cells (positive for caspase 3; Casp3+) from at least six high-power fields (HPF, 400 x magnification) per animal were determined microscopically in immunohistochemically stained ileal paraffin sections. Numbers of animals (in parentheses), medians and significance levels (p-values) determined by Students-t test and Mann-Whitney U test are indicated. Data shown were pooled from three independent experiments.
Intestinal inflammatory immune responses upon T. gondii infection of human microbiota associated mice
We further surveyed microscopic inflammatory sequelae and therefore quantitatively assessed small intestinal immune cell responses in hma mice at day 7 post ileitis induction. Numbers of T and B lymphocytes, Treg as well as of macrophages and monocytes substantially increased within the ileal mucosa and lamina propria of hma mice until day 7 p.i. (p<0.05–0.001; Fig 3, S2C–S2F Fig). Ileal increases in innate and adaptive immune cell populations were accompanied by elevated small intestinal secretion of pro-inflammatory cytokines such as IFN-γ and IL-12p70 at day 7 p.i. (p<0.001 and p<0.01, respectively; Fig 4A). Remarkably, pro-inflammatory responses were not restricted to the ileum, given that T. gondii infection also resulted in increased IFN-γ and nitric oxide concentrations in colonic ex vivo biopsies (p<0.001 and p<0.01, respectively; Fig 4B), whereas IFN-γ and IL-12p70 levels increased multifold in MLN of hma mice with acute ileitis (p<0.001 and p<0.05, respectively; Fig 4C). Furthermore, concentrations of the anti-inflammatory cytokine IL-10 were higher in MLN of T. gondii infected as compared to noninfected hma mice (p<0.001; Fig 4). Hence, peroral T. gondii infection induces marked pro-inflammatory immune responses in the intestines of hma mice.
Human microbiota associated (hma) mice were perorally infected with T. gondii strain ME49 to induce acute ileitis (ILE; grey boxes). Noninfected hma mice served as controls (N, white boxes). The average numbers of ileal (A) T lymphocytes (positive for CD3), (B) regulatory T cells (positive for FOXP3), (C) B lymphocytes (positive for B220), and (D) macrophages (positive for F4/80) from six high power fields (HPF, 400 x magnification) per animal were determined microscopically in immunohistochemically stained ileal paraffin sections at day 7 post ileitis induction. Box plots represent the 75th % and 25th % percentiles of the medians (black bar inside the boxes). Total range and significance levels (p-values) determined by the Student’s t test and Mann-Whitney U test and numbers of mice (in parentheses) are indicated. Data shown were pooled from three independent experiments.
Human microbiota associated (hma) mice were perorally infected with T. gondii strain ME49 to induce acute ileitis (ILE; grey boxes). Noninfected hma mice served as controls (N, white boxes). At day 7 post ileitis induction secretion of distinct pro- and anti-inflammatory cytokines (as indicated) were determined in ex vivo biopsies derived from distinct intestinal compartments including (A) ileum (B) colon and (C) mesenteric lymph nodes (MLN). Box plots represent the 75th % and 25th % percentiles of the medians (black bar inside the boxes). Total range and significance levels (p-values) determined by the Student’s t test and Mann-Whitney U test and numbers of mice (in parentheses) are indicated. Data shown were pooled from three independent experiments.
Bacterial translocation in T. gondii infected human microbiota associated mice
We next addressed whether viable intestinal commensal bacteria had translocated from the inflamed (and hence leaky) ilea to extra-intestinal including systemic compartments. As assessed by direct plating, commensals such as enterobacteria, enterococci and Bacteroides / Prevotella spp. that had overgrown the inflamed ileal lumen during ileitis could be isolated from MLN of all mice and from liver and lung in 85.0 ± 21.2% of cases at day 7 p.i. (Figs 5 and 6). Remarkably, viable bacteria could also be detected in systemic compartments as indicated by translocation rates of 36.7 ±4.7% and 10.0 ±14.1% in spleen and cardiac blood, respectively (Figs 5 and 6). Of note, commensal bacteria could be cultured from respective organ homogenates and blood derived from naive mice in single cases only (Figs 5 and 6).
Human microbiota associated (Hma) mice were perorally infected with T. gondii strain ME49 to induce acute ileitis (ILE, filled bars). Noninfected hma mice served as controls (N, open bars). At day 7 post ileitis induction rates of viable intestinal bacterial species translocating to extra-intestinal and systemic compartments were determined by cultivation of ex vivo biopsies derived from mesenteric lymph nodes (MLN), liver, lung and spleen and of cardiac blood. Mean translocation rates (in %) ± standard deviations and numbers of culture-positive samples out of the total number of analyzed animals are indicated in parentheses. Data shown were pooled from three independent experiments.
Human microbiota associated (hma) mice were perorally infected with T. gondii strain ME49 to induce acute ileitis (ILE, filled circles). Noninfected hma mice served as controls (N, open circles). At day 7 post ileitis induction viable intestinal bacteria translocating to (A) MLN, (B) extra-intestinal (i.e. liver and lung) and (C) systemic compartments (i.e. spleen and blood) were quantitatively determined by culture of respective ex vivo biopsies and cardiac blood. Numbers of enterobacteria (EB), enterococci (EC), Gram-positive rods (GPR), Bacteroides / Prevotella species (B/P), Clostridium / Eubacterium species (C/E) and the total bacterial loads (TL) were expressed as colony forming units per gram organ homogenate or ml blood (CFU/g; CFU/ml). Numbers of culture-positive samples out of the total number of analyzed mice are given in parentheses. Medians (black bars) and significance levels (p-values) determined by Mann-Whitney U test are indicated. Data shown were pooled from three independent experiments.
Extra-intestinal including systemic inflammatory responses in T. gondii infected human microbiota associated mice
We next assessed whether T. gondii induced inflammatory responses could also be observed in extra-intestinal compartments. In fact, IFN-γ and nitric oxide concentrations were multifold higher in ex vivo biopsies derived from liver and kidney of hma mice at day 7 p.i. as compared to noninfected hma control animals (p<0.01–0.001; Fig 7). In addition, renal TNF and MCP-1 levels increased in hma mice upon ileitis induction (p<0.001; Fig 7B). Remarkably, T. gondii infection of hma mice also resulted in pronounced systemic pro-inflammatory immune responses, given that serum levels of pro-inflammatory cytokines including IFN-γ, TNF, MCP-1, IL-12p70 and IL-6 were all multifold elevated at day 7 p.i. (p<0.05–0.001 vs noninfected controls; Fig 8A) and paralleled by increased IFN-γ secretion in splenic ex vivo biopsies taken from hma mice with ileitis (p<0.01 vs noninfected controls; Fig 8B). Furthermore, serum concentrations of the anti-inflammatory cytokine IL-10 were higher in infected as compared to naive hma mice (p<0.001; Fig 8A). Hence, T. gondii infection of hma mice was accompanied by translocation of commensal bacteria from the inflamed small intestines to extra-intestinal compartments and resulted not only in intestinal, but also extra-intestinal and systemic inflammatory immune responses.
Human microbiota associated (hma) mice were perorally infected with T. gondii strain ME49 to induce acute ileitis (ILE; grey boxes). Noninfected hma mice served as controls (N, white boxes). At day 7 post ileitis induction secretion of distinct pro-inflammatory cytokines (as indicated) were determined in ex vivo biopsies derived from distinct extra-intestinal compartments including (A) liver and (B) kidney. Box plots represent the 75th % and 25th % percentiles of the medians (black bar inside the boxes). Total range and significance levels (p-values) determined by the Student’s t test and Mann-Whitney U test and numbers of mice (in parentheses) are indicated. Data shown were pooled from three independent experiments.
Human microbiota associated mice were perorally infected with T. gondii strain ME49 to induce acute ileitis (ILE; grey boxes). Noninfected hma mice served as controls (N, white boxes). At day 7 following ileitis induction secretion of distinct pro- and anti-inflammatory cytokines were determined in systemic compartments including (A) serum and (B) spleen (as indicated). Box plots represent the 75th % and 25th % percentiles of the medians (black bar inside the boxes). Total range and significance levels (p-values) determined by the Student’s t test and Mann-Whitney U test and numbers of mice (in parentheses) are indicated. Data shown were pooled from three independent experiments.
In the present study we surveyed the suitability of (with respect to the microbiota) “humanized” mice to study the interactions between pathogen, human commensal microbiota and host immunity during acute T. gondii induced ileitis. Therefore, secondary abiotic mice were generated by broad-spectrum antibiotic treatment and subsequently subjected to peroral FMT. Despite originating from a foreign host, the complex human microbiota was able to fully establish in the murine intestinal tract within three weeks before ileitis induction. In addition to a “classical” culture-based survey of the intestinal microbiota composition we applied culture-independent (i.e. quantitative 16S rRNA based real-time PCR) methods to also assess fastidious or even uncultivable bacteria including bifidobacteria, clostridia and Mouse Intestinal Bacteroides. One needs to take into consideration, however, that it can not be distinguished whether amplified 16S rRNA gene copies were derived form viable or “dead” bacterial cells. The here presented comprehensive survey of the intestinal microbiota in “humanized” mice was further supported by our previous studies where the human microbiota composition was stable in the murine gastrointestinal tract for at least six weeks following FMT [14, 25]. In addition, it could be shown that the microbiota of hma mice remained stable over several generations . High dose infection of hma mice with at least 50 cysts of T. gondii resulted in severe macroscopic and microscopic pro-inflammatory sequelae as indicated by wasting, bloody diarrhea and acute transmural ileitis with both apoptosis and necrosis that were comparable to disease outcomes in T. gondii infected conventionally colonized mice as shown in several previous reports [5, 9, 11, 17, 23, 24, 27–31]. In both conventional and hma mice this non-selflimiting T cell-driven inflammatory scenario was further characterized by excessive ileal secretion of pro-inflammatory cytokines including IFN-γ and IL-12. So far, the ileum has been described as the exclusive intestinal predilection site of high dose T. gondii infection . Strikingly, we were able to show here that T. gondii infection resulted in enhanced secretion of pro-inflammatory mediators (including IFN-γ and nitric oxide) also in the large intestines.
The intriguing role of the intestinal microbiota in initiation and perpetuation of T. gondii induced ileitis could be proven by our previous and actual in vivo studies, given that secondary abiotic mice were virtually unaffected from T. gondii infection, whereas with a complex microbiota recolonized mice (irrespective whether of murine  or human origin as shown here) were exhibiting the full-blown disease. Similar to conventional mice [9, 11], small intestinal inflammation was accompanied by substantial shifts in the ileal microbiota composition of hma mice towards a marked overgrowth of the inflamed ileal, but also (to a lesser extent) colonic lumen with Gram-negative commensal species such as E. coli and Bacteroides / Prevotella spp. Importantly, comparable microbiota shifts can also be observed in Crohn’s disease patients during the acute stage [32–35]. Similar to conventionally colonized mice, the in the course of the inflammatory process compromised intestinal epithelial barrier function (i.e. “leaky gut”) resulted in translocation of viable intestinal commensals overgrowing the ileal lumen to extra-intestinal including systemic compartments (i.e. liver, lung, spleen and blood), further aggravating the inflammatory process as indicated by an exaggerated increase in inflammatory cytokines (including IFN-, TNF, MCP-1, IL-12, IL-6 and IL-10) in the serum taken from hma mice with acute ileitis (“cytokine storm” ). Hence, our results further emphasize the feasibility of the hma mouse model in investigating microbiota-host interactions and their underlying molecular mechanisms during intestinal inflammation mimicking human flora conditions.
The hma mouse model has been further proven valuable in dissecting the interplay between enteropathogens such as Campylobacter jejuni, the host microbiota and immunity [8, 13, 14]. Whereas conventionally colonized mice could not be infected by the pathogen, hma mice harbored C. jejuni in their gastrointestinal tract at high loads and exhibited pro-inflammatory key features of human campylobacteriosis [14, 36]. Very recently, Collins and colleagues presented an hma mouse model of recurrent Clostridium difficile infection during antimicrobial therapy . Hma rodents have been further used in intestinal inflammation models in order to investigate host susceptibility to disease depending on a defined human microbiota that had been derived from healthy and diseased individuals [37, 38]. Furthermore, hma isolator-raised (formerly germ-free) mice were applied in several studies for dissecting intestinal microbiota changes upon different diets and during obesity [39–42]. Since immunological differentiation and stimulation are highly microbiota dependent, secondary abiotic mice have the advantage of a fully developed immune system . This point of view is shared by previous studies reporting pivotal differences in phenotypes already under basal conditions and even more pronounced in various disease states when applying isolator-raised germfree and conventionally reared mice [43–46].
We conclude that hma secondary abiotic mice that were generated by antibiotic treatment of conventionally reared mice represent valuable tools for studies investigating the molecular mechanism underlying distinct microbiota—host interactions in health and disease including acute intestinal inflammation.
S1 Fig. Microbiota composition of human donor feces.
Before fecal microbiota transplantation of secondary abiotic mice, main intestinal bacterial groups were quantitatively assessed in human donor fecal suspensions. (A) Numbers of viable enterobacteria (EB), enterococci (EC), Gram-positive rods (GPR), Bacteroides / Prevotella species (B/P), Clostridium / Eubacterium species (C/E) and the total bacterial load (TL) were determined by culture and expressed as colony forming units (CFU) per ml suspension. (B) 16S rRNA of the main intestinal bacterial commensals including enterobacteria (EB), enterococci (EC), lactobacilli (LB), bifidobacteria (Bif), Bacteroides / Prevotella species (B/P), Clostridium coccoides group (Clocc), Clostridium leptum group (Clept), Mouse Intestinal Bacteroides (MIB) and the total eubacterial load (TL) were analyzed by quantitative RT-PCR and expressed as gene numbers per ng DNA. Data shown are representative for at least three independent experiments.
S2 Fig. Immunohistopathological changes in small intestines of human microbiota associated mice suffering from acute ileitis.
Human microbiota associated (hma) and conventionally colonized (SPF) mice were perorally infected with T. gondii strain ME49 to induce acute ileitis. Noninfected mice served as respective naive controls. Small intestinal immunohistopathological changes were assessed at day (d) 7 following ileitis induction in ileal paraffin sections stained with (A) hematoxylin & eosin or antibodies against (B) caspase-3, (C) CD3, (D) FOXP3, (E) B220 or (F) F4/80. Representative photomicrographs from three independent experiments are shown (A, C, D: 100 x magnification, scale bars 100 μm; B, E, F: 400 x magnification, scale bars 20 μm).
We thank Michaela Wattrodt, Ursula Rüschendorf, Alexandra Bittroff-Leben, Ines Puschendorf, Gernot Reifenberger and the staff of the animal research facility at Charité—University Medicine Berlin for excellent technical assistance and animal breeding.
- Conceptualization: EVK MMH.
- Data curation: EVK IE AAK SB MMH.
- Formal analysis: EVK IE AAK MMH.
- Funding acquisition: SB MMH.
- Investigation: EVK IE AAK SB MMH.
- Methodology: EVK AAK MMH.
- Project administration: EVK SB MMH.
- Resources: SB AAK MMH.
- Software: SB.
- Supervision: MMH.
- Validation: EVK AAK SB MMH.
- Visualization: EVK IE AAK MMH.
- Writing – original draft: EVK MMH.
- Writing – review & editing: EVK IE AAK SB MMH.
- 1. McLeod R, Eisenhauer P, Mack D, Brown C, Filice G, Spitalny G. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J Immunol. 1989;142(9):3247–55. pmid:2496163
- 2. McLeod R, Skamene E, Brown CR, Eisenhauer PB, Mack DG. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. J Immunol. 1989;143(9):3031–4. pmid:2809214
- 3. Munoz M, Liesenfeld O, Heimesaat MM. Immunology of Toxoplasma gondii. Immunol Rev. 2011;240(1):269–85. pmid:21349099
- 4. Liesenfeld O, Kosek J, Remington JS, Suzuki Y. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med. 1996;184(2):597–607. pmid:8760813
- 5. Liesenfeld O, Kang H, Park D, Nguyen TA, Parkhe CV, Watanabe H, et al. TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol. 1999;21(7):365–76. pmid:10417671
- 6. Vossenkamper A, Struck D, Alvarado-Esquivel C, Went T, Takeda K, Akira S, et al. Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Eur J Immunol. 2004;34(11):3197–207. pmid:15368276
- 7. Jankovic D, Kugler DG, Sher A. IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol. 2010;3(3):239–46. pmid:20200511
- 8. Fiebiger U, Bereswill S, Heimesaat MM. Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp). 2016;6(4):253–71.
- 9. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol. 2006;177(12):8785–95. Epub 2006/12/05. pmid:17142781
- 10. Erridge C, Duncan SH, Bereswill S, Heimesaat MM. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One. 2010;5(2):e9125. pmid:20161736
- 11. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, Blaut M, et al. Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut. 2007;56(7):941–8. Epub 2007/01/27. pmid:17255219
- 12. Liesenfeld O. Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis. 2002;185 Suppl 1:S96–101.
- 13. Masanta WO, Heimesaat MM, Bereswill S, Tareen AM, Lugert R, Gross U, et al. Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Develop Immunol. 2013;2013:526860.
- 14. Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kuhl AA, et al. Novel murine infection models provide deep insights into the "menage a trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS One. 2011;6(6):e20953. pmid:21698299
- 15. Heimesaat MM, Nogai A, Bereswill S, Plickert R, Fischer A, Loddenkemper C, et al. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut. 2010;59(8):1079–87. pmid:20639251
- 16. Bereswill S, Munoz M, Fischer A, Plickert R, Haag LM, Otto B, et al. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One. 2010;5(12):e15099. pmid:21151942
- 17. Struck D, Frank I, Enders S, Steinhoff U, Schmidt C, Stallmach A, et al. Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18. Eur J Microbiol Immunol (Bp). 2012;2(3):249–57.
- 18. Golz G, Karadas G, Alutis ME, Fischer A, Kuhl AA, Breithaupt A, et al. Arcobacter butzleri Induce Colonic, Extra-Intestinal and Systemic Inflammatory Responses in Gnotobiotic IL-10 Deficient Mice in a Strain-Dependent Manner. PLoS One. 2015;10(9):e0139402. pmid:26406497
- 19. Alutis ME, Grundmann U, Fischer A, Hagen U, Kuhl AA, Gobel UB, et al. The Role of Gelatinases in Campylobacter Jejuni Infection of Gnotobiotic Mice. Eur J Microbiol Immunol (Bp). 2015;5(4):256–67.
- 20. Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, Fuchs D, et al. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One. 2007;2(7):e662. Epub 2007/07/27. pmid:17653282
- 21. Rausch S, Held J, Fischer A, Heimesaat MM, Kuhl AA, Bereswill S, et al. Small intestinal nematode infection of mice is associated with increased enterobacterial loads alongside the intestinal tract. PLoS One. 2013;8(9):e74026. pmid:24040152
- 22. Thoene-Reineke C, Fischer A, Friese C, Briesemeister D, Gobel UB, Kammertoens T, et al. Composition of intestinal microbiota in immune-deficient mice kept in three different housing conditions. PLoS One. 2014;9(11):e113406. pmid:25401702
- 23. Heimesaat MM, Dunay IR, Alutis M, Fischer A, Mohle L, Gobel UB, et al. Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis. PLoS One. 2014;9(8):e105120. pmid:25141224
- 24. Heimesaat MM, Dunay IR, Schulze S, Fischer A, Grundmann U, Alutis M, et al. Pituitary adenylate cyclase-activating polypeptide ameliorates experimental acute ileitis and extra-intestinal sequelae. PLoS One. 2014;9(9):e108389. pmid:25238233
- 25. Heimesaat MM, Boelke S, Fischer A, Haag LM, Loddenkemper C, Kuhl AA, et al. Comprehensive postmortem analyses of intestinal microbiota changes and bacterial translocation in human flora associated mice. PLoS One. 2012;7(7):e40758. pmid:22808253
- 26. Collins J, Auchtung JM, Schaefer L, Eaton KA, Britton RA. Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome. 2015;3:35. pmid:26289776
- 27. Munoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, Plickert R, et al. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med. 2009;206(13):3047–59. Epub 2009/12/10. pmid:19995958
- 28. Heimesaat MM, Plickert R, Fischer A, Gobel UB, Bereswill S. Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni? Eur J Microbiol Immunol (Bp). 2013;3(1):36–43.
- 29. Berrocal Almanza LC, Munoz M, Kuhl AA, Kamradt T, Heimesaat MM, Liesenfeld O. Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii. Eur J Microbiol Immunol (Bp). 2013;3(3):211–21.
- 30. Bereswill S, Kuhl AA, Alutis M, Fischer A, Mohle L, Struck D, et al. The impact of Toll-like-receptor-9 on intestinal microbiota composition and extra-intestinal sequelae in experimental Toxoplasma gondii induced ileitis. Gut Pathog. 2014;6:19. pmid:24932221
- 31. Heimesaat MM, Fischer A, Kuhl AA, Gobel UB, Gozes I, Bereswill S. Anti-Inflammatory Properties of NAP in Acute Toxoplasma Gondii-Induced Ileitis in Mice. Eur J Microbiol Immunol (Bp). 2015;5(3):210–20.
- 32. Masseret E, Boudeau J, Colombel JF, Neut C, Desreumaux P, Joly B, et al. Genetically related Escherichia coli strains associated with Crohn's disease. Gut. 2001;48(3):320–5. pmid:11171820
- 33. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003;52(2):237–42. pmid:12524406
- 34. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127(2):412–21. pmid:15300573
- 35. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005;43(7):3380–9. pmid:16000463
- 36. Alter T, Bereswill S, Glunder G, Haag LM, Hanel I, Heimesaat MM, et al. [Campylobacteriosis of man: livestock as reservoir for Campylobacter species]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2011;54(6):728–34. pmid:21626378
- 37. Eun CS, Mishima Y, Wohlgemuth S, Liu B, Bower M, Carroll IM, et al. Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice. Infect Immun. 2014;82(6):2239–46. pmid:24643531
- 38. Natividad JM, Pinto-Sanchez MI, Galipeau HJ, Jury J, Jordana M, Reinisch W, et al. Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model. Inflamm Bowel Dis. 2015;21(8):1883–93. pmid:26060932
- 39. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1(6):6ra14. pmid:20368178
- 40. Faith JJ, McNulty NP, Rey FE, Gordon JI. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science. 2011;333(6038):101–4. pmid:21596954
- 41. Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, Dantas G, et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A. 2011;108(15):6252–7. pmid:21436049
- 42. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med. 2011;3(106):106ra.
- 43. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180(6):2359–64. pmid:7964509
- 44. Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, Owen MJ. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol. 1997;150(1):91–7. pmid:9006326
- 45. Hansen AK, Hansen CH, Krych L, Nielsen DS. Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol. 2014;20(47):17727–36. pmid:25548471
- 46. Hazebrouck S, Przybylski-Nicaise L, Ah-Leung S, Adel-Patient K, Corthier G, Wal JM, et al. Allergic sensitization to bovine beta-lactoglobulin: comparison between germ-free and conventional BALB/c mice. Int Arch Allergy Immunol. 2009;148(1):65–72. pmid:18716405